References
- Cumming A D, Robertson C E, Jeffrey S S, Robson J S, Ledingham I M. The plasma kallikrein kinin system in severely ill and traumatised patients. Arch Emerg Med. 1984; 3: 135–142
- Hirsch E F, Nakajima T., Oshima G, Erdos E G, Herman C M. Kinin system responses in sepsis after trauma in man. J Surg Res. 1974; 17: 147–153
- Hesselvik J F, Blomback M, Brodin B, Maller R. Coagulation, fibrinolysis, and kallikrein systems in sepsis: relation to outcome. Crit Care Med. 1989; 17: 724–733
- Kalter E S, Daha M R, Ten Cate J W, Verhoef J, Bouma B N. Activation and inhibition of Hage-man factor-dependent pathways and the complement system in uncomplicated bacteremia or bacterial shock. J Infect Dis. 1985; 151: 1019–1027
- Martinez Brotons F, Oncins J R, Mestres J, Amargos V, Reynaldo C. Plasma kallikrein-kinin system in patients with uncomplicated sepsis and septic shock: comparison with cardiogenic shock. Thromb Haemost. 1987; 58: 709–713
- de Oliveira G G, Antonio M P. Adult respiratory distress syndrome (ARDS): the pathophysiologic role of catecholamine-kinin interactions. J Trauma. 1988; 28: 246–253
- Weipert J, Hoffmann H, Siebeck M, Whalley E T. Endotoxin shock in the rat: reduction of arterial blood pressure fall by the bradykinin antagonist B4148. Prog Clin Biol Res. 1989; 308: 983–987
- Whalley E T, Solomon J A, Modafferi D M, Bonham K A, Cheronis J C. CP-0127, a novel potent bradykinin antagonist, increases survival in rat and rabbit models of endotoxin shock. Agents Actions Suppl. 1992; 38: 413–420
- Wilson D D, de Garavilla L, Kuhn W, Togo J, Burch R M, Steranka L R. D-Arg-<Hyp3-D-Phe7>-bradykinin, a bradykinin antagonist, reduces mortality in a rat model of endotoxic shock. Circ Shock 1989; 27: 93–101
- Byrne K, Sugerman H J. Experimental and clinical assessment of lung injury by measurement of extravascular lung water and transcapillary protein flux in ARDS: a review of current techniques. J Surg Res. 1988; 44: 185–203
- Colman R W. The role of plasma proteases in septic shock. N Eng J Med. 1989; 320: 1207–1209
- Steranka L R, Farmer S G, Burch R M. Antagonists of B2 bradykinin receptörs. FASEB J. 1989; 3: 2019–2025
- Mullins R J. Bradykinin causes a prolonged increase in skin microvascular permeability. J Surg Res. 1986; 40: 540–549
- Mullins R J, Malias M A, Hudgens R W. Isoproterenol inhibits the increase in microvascular membrane permeability produced by bradykinin. J Trauma. discus. 1989; 29: 1053–63
- Kline R L, Scott J B, Haddy F J, Grega G J. Mechanism of edema formation in canine forelimbs by locally administered bradykinin. Am J Physiol. 1973; 225(5)1051–1056
- Schini V B, Boulanger C, Regoli D, Vanhoutte P M. Bradykinin stimulates the production of cyclic GMP via activation of 82 kinin receptors in cultured porcine aortic endothelial cells. J Pharmacol Exp Ther. 1990; 252: 581–585
- Ignarro L J, Byms R E, Buga G M, Wood K S. Mechanisms of endothelium-dependent vascular smooth muscle relaxation elicited by bradykinin and VIP. Am J Physiol. 1987; 253: H1074–H1082
- Majno G, Shea S M, Leventhal M. Endothelial contraction induced by histamine-type mediators. J Cell Biol. 1969; 42: 647–670
- Windsor A CJ, Mullen P G, Walsh C J. Delayed tumor necrosis factor blockade attenuates pulmonary dysfunction and metabolic acidosis associated with experimental gram-negative sepsis. Arch Surg. 1994; 129: 80–89
- Carey P D, Byrne K, Jenkins J K. Ibuprofen attenuates hypochlorous acid production from neutrophils in porcine acute lung injury. J Surg Res. 1990; 49: 262–270